H.U. Group Holdings, Inc. (TYO:4544)

Japan · Delayed Price · Currency is JPY

3,879.00

-49.00 (-1.25%)

Nov 4, 2026, 3:30 PM JST

Market Cap	209.80B -1.8%
Revenue (ttm)	248.56B +1.5%
Net Income	9.59B +590.7%
EPS	171.85 +603.0%
Shares Out	54.09M
PE Ratio	22.57
Forward PE	33.92
Dividend	125.00 (3.22%)
Ex-Dividend Date	Sep 29, 2026

Volume	182,500
Open	3,901.00
Previous Close	3,928.00
Day's Range	3,861.00 - 3,953.00
52-Week Range	2,944.50 - 3,999.00
Beta	0.29
Analysts	Sell
Price Target	3,146.67 (-18.88%)
Earnings Date	Nov 11, 2026

About H.U. Group Holdings

H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing (WGS) and proteome analysis; support for clinical trials and research, including pre-trial setup work, specimen collection and tra... [Read more]

Industry Medical - Diagnostics & Research

Sector Healthcare

Founded 1950

Employees 5,157

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4544

Full Company Profile

Financial Performance

In fiscal year 2026, H.U. Group Holdings's revenue was 247.36 billion, an increase of 1.78% compared to the previous year's 243.03 billion. Earnings were 6.82 billion, an increase of 147.12%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 4544 stock is "Sell." The 12-month stock price target is ¥3,147, which is a decrease of -18.88% from the latest price.

Price Target

¥3,147

(-18.88% downside)

Analyst Consensus: Sell

Stock Forecasts